Tie-1 tyrosine kinase expression in human thyroid neoplasms

Histopathology

Volumn 44, Issue 4, 2004, Pages 318-322

  Ito, Y ^a   Yoshida, H ^a   Uruno, T ^a   Nakano, K ^a   Takamura, Y ^a   Miya, A ^a   Kobayashi, K ^a   Yokozawa, T ^a   Matsuzuka, F ^a   Kuma, K ^a   Miyauchi, A ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

Immunohistochemistry; Thyroid; Tie 1

Indexed keywords

PROTEIN TYROSINE KINASE; TIE 1 RECEPTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; OVARY FOLLICLE CELL; PAPILLARY CARCINOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CANCER;

CARCINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTOR, TIE-1; THYROID GLAND; THYROID NEOPLASMS;

EID: 11144356459     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2003.01805.x     Document Type: Article

References (19)

1. Aldinger KA, Samaan NA, Ibanez M, Hill CS Jr. Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant-cell carcinoma of the thyroid. Cancer 1978; 41; 2267-2275.
2. Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathological entity for a high-risk group of papillary and follicular carcinomas. Cancer 1983; 52; 1849-1855.
3. Dickson RB, Salomon DS, Lippman ME. Tyrosine kinase receptor-nuclear protooncogene interactions in breast cancer. Cancer Treat. Res. 1992; 61; 249-273.
4. Hsuan JJ. Oncogene regulation by growth factors. Anticancer Res. 1993; 13; 2521-2532.
5. Cantley LC, Auger KR, Carpenter C et al. Oncogenes and signal transduction. Cell 1991; 62; 281-302.
6. Partanen J, Armstrong E, Makela T et al. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol. Cell Biol. 1992; 12; 1698-1707.
7. Hatva E, Vlaykowa T, Jaaskelainen J et al. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am. J. Pathol. 1995; 146; 368-378.
8. Kaipainen A, Vlaykowa T, Hatva E et al. Enhanced expression of the tie receptor tyrosine kinase gene in the vascular endothelium of metastatic melanomas. Cancer Res. 1994; 54; 6571-6577.
9. Salven P, Joensuu H, Heikkila P et al. Endothelial tie growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis. Br. J. Cancer 1996; 74; 69-72.
10. Lin WC, Li AFY, Chi CW et al. Tie-1 protein tyrosine kinase: a novel independent prognostic marker for gastric cancer. Clin. Cancer Res. 1999; 5; 1745-1751.
11. Tseng LM, Hsu CY, Wang HC et al. Tie-1 tyrosine kinase is an independent prognostic idicator for invasive breast cancer. Anticancer Res. 2001; 21; 2163-2170.
12. Akslen LA, Livolsi VA. Increased angiogenesis in papillary thyroid carcinoma but lack of prognostic importance. Hum. Pathol. 2000; 31; 439-442.
13. Dhar DK, Kubota H, Kotoh T et al. Tumor vascularity predicts recurrence in differentiated thyroid carcinoma. Am. J. Surg. 1998; 176; 442-447.
14. Huang SM, Lee JC, Wu TJ, Chow NH. Clinical relevance of vascular endothelial growth factor for thyroid neoplasms. World J. Surg. 2001; 25; 302-306.
15. Soh EY, Eigelberger MS, Kim KJ et al. Neutralizing vascular endothelial growth factor activity inhibits thyroid cancer growth in vivo. Surgery 2000; 128; 1059-1065.
16. Mitsutake N, Namba H, Takahara K et al. Tie-2 and angiopoietin-1 expression in human thyroid tumors. Thyroid 2002; 12; 95-99.
17. Bunone G, Vigneri P, Mariani L et al. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am. J. Pathol. 1999; 155; 1967-1976.
18. Tanaka K, Sonoo H, Kurebayashi J et al. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinioma. Clin. Cancer Res. 2002; 8; 1122-1131.
19. Shah JP, Loree TR, Dharker D et al. Prognostic factors in differentiated carcinoma of the thyroid gland. Am. J. Surg. 1992; 164; 658-661.